Putative uncharacterized protein ORFI in retron EC67 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Putative uncharacterized protein ORFI in retron EC67 antibody
Uniprot No.

Q&A

What is Retron EC67 and how does it function in bacterial defense systems?

Retron EC67 is a bacterial genetic retroelement found in certain strains of Escherichia coli that functions as an anti-phage defense system. It consists of a reverse transcriptase (RT) enzyme, non-coding RNA (ncRNA), and an effector protein that is uniquely fused to the RT gene. The system produces a branched-RNA-linked multicopy single-stranded DNA (msDNA-EC67) that plays a critical role in its defensive function .

Retron EC67 protects bacteria through an abortive infection mechanism. When specific phage proteins involved in DNA degradation are detected (such as protein A1 in T5n/ΦSP15m phages or DenB in T2 phages), the retron system activates, triggering cell death before the phage can complete its replication cycle . This "altruistic suicide" protects the broader bacterial population from phage predation.

The retron EC67 element is found within a unique 34-kilobase sequence flanked by 26-base-pair direct repeats in the E. coli genome, suggesting it was acquired through horizontal gene transfer, potentially via transposition or phage integration mechanisms . This genomic organization is characteristic of bacterial defense islands, where multiple defense mechanisms cluster together.

How do researchers experimentally validate the function of uncharacterized proteins in Retron EC67?

Characterizing uncharacterized proteins like ORFI in retron EC67 requires a multi-faceted experimental approach:

1. Bioinformatic analysis and candidate domain identification:

  • Sequence homology searches against protein databases

  • Structure prediction using tools like AlphaFold

  • Domain prediction to identify functional motifs (search results suggest PRTase-like domains and winged helix-turn-helix domains are present in some retron effector proteins)

2. Protein expression and purification:

  • Clone ORFI gene into expression vectors with affinity tags

  • Optimize expression conditions in bacterial systems

  • Purify using affinity chromatography followed by additional purification steps

3. Mutational analysis:

  • Create point mutations in conserved residues or domains

  • Test effects on retron function using phage challenge assays

  • Recent studies on related retrons demonstrated that mutations in key residues (such as E117Q in the catalytic site of a ribosyltransferase domain) abolished defense function

4. Functional assays:

  • Phage resistance assays with wildtype vs. mutant ORFI variants

  • In vitro biochemical assays to identify enzymatic activities

  • Pull-down experiments to identify interaction partners

Mutation TypeTypical Effect on Retron FunctionExample from Literature
RT catalytic siteComplete loss of functionD216A/D217A mutations in Retron Ec48 RT
ncRNA branching GLoss of msDNA synthesisG>C mutation at position 17 of ncRNA
Effector domainLoss of cell death responseE117Q in ribosyltransferase domain
Domain interfacesDisrupted signal transductionVarious conserved residues in Rad (R13E, P33T, I88T)

5. Antibody development:

  • Generate peptide or recombinant protein antigens

  • Produce and validate antibodies using western blotting and immunoprecipitation

  • Deploy antibodies for localization and interaction studies

6. CRISPR-based approaches:

  • Generate precise knockouts or domain deletions

  • Create reporter fusions to monitor expression and localization

  • Perform high-throughput functional screens

What mechanisms do phages employ to overcome Retron EC67-mediated defense?

Phages have evolved sophisticated mechanisms to counteract retron-based defense systems, including Retron EC67:

1. Anti-retron proteins:

  • The Rad (retron anti-defense) protein identified in phage ΦSP15 effectively neutralizes multiple retron systems, including Retron EC67

  • Rad functions by degrading the non-coding RNA (ncRNA) component of retrons, preventing msDNA synthesis and subsequent defense activation

  • Structural analysis reveals Rad contains primase/helicase and TOPIRM/RNase domains that target retron ncRNA

  • Homology searches identified 541 Rad homologues across 19,263 phage genomes, primarily in Siphoviridae and Myoviridae families

2. Mutation of triggering factors:

  • Phages can acquire mutations in specific proteins that typically trigger retron defense

  • For Retron EC67, all escaper mutants of T5n/ΦSP15m phages showed mutations in protein A1, while T2 phage escapers had mutations in DenB

  • Both protein A1 and DenB are involved in DNA degradation during infection

3. tRNA supplementation:

  • Some phages encode their own tRNAs to counter specific retron systems

  • While primarily documented for Retron Ec78 (where the phage-encoded tRNATyr neutralizes the defense by replacing bacterial tRNATyr targeted by the retron effector), this mechanism exemplifies the diverse counter-strategies phages employ

4. Co-evolution dynamics:

  • The genomic organization of anti-retron elements in phages suggests evolutionary pressure

  • Anti-defense genes often co-localize in phage genomes, forming "anti-defense islands"

  • Phage T5n contains multiple anti-defense elements in its ADI (anti-defense island) region

Figure 1: Effectiveness of Rad Mutations Against Retron Defense

Rad MutationRelative Anti-Retron Activity (%)
Wild-type100
R13E~40
P33T~60
I88T~45
D135H~30
E156H~35
Double mutations<5

Data derived from research on Rad protein effects on retron defense

How does the structure of Retron EC67 msDNA relate to its function in anti-phage defense?

The structure and biogenesis of msDNA in Retron EC67 is intrinsically linked to its anti-phage defense function:

1. Structural characteristics:

  • msDNA-EC67 is a single-stranded DNA molecule approximately 67 bases long

  • It remains covalently linked to RNA via a unique 2'-5' phosphodiester bond

  • The RNA-DNA junction contains a conserved guanosine residue that serves as the branching point

  • Secondary structures form within the msDNA through complementary base pairing

2. Biogenesis pathway:

  • Transcription of the retron locus produces an ncRNA precursor

  • The retron-encoded RT recognizes specific structural features in the ncRNA, particularly the branching G residue

  • Reverse transcription initiates at this G residue, creating the 2'-5' phosphodiester bond between RNA and DNA

  • The RT continues synthesis using the ncRNA as template

  • Host RNase H1 plays a role in removing parts of the RNA template and determining the termination point of RT-DNA

3. Functional significance:

  • Point mutations in the ncRNA that disrupt the branching G residue (G>C at position 17) completely abolish defense function

  • Similarly, mutations in a second conserved G residue (G>A at position 147) also eliminate defense capability

  • This demonstrates that proper synthesis of msDNA is essential for defense activation

4. Role in retron complex formation:

  • In related retron systems, the msDNA is essential for effector protein binding to the RT

  • When mutations prevent msDNA formation, effector proteins fail to associate with the retron complex

  • This suggests msDNA may function as a structural component that stabilizes protein interactions within the defense complex

5. Potential sensing mechanism:

  • The msDNA may interact with cellular components to monitor bacterial processes

  • When phage proteins disrupt these interactions (e.g., by binding to the same cellular targets), it could trigger conformational changes in the retron complex

  • This would activate the effector protein, leading to cell death via abortive infection

6. Species-specific variations:

  • The precise size and sequence of msDNA varies between different retron systems

  • Retron EC67 produces msDNA of approximately 67 bases, while other retrons produce msDNA of different lengths

  • These variations likely reflect adaptation to different phage threats and cellular contexts

What is the relationship between Retron EC67 and other bacterial defense systems?

Retron EC67 operates within a sophisticated network of bacterial defense mechanisms:

1. Genomic co-localization in defense islands:

  • Retron EC67 is typically found in genomic "defense islands" alongside other bacterial immune systems

  • This clustering facilitates horizontal transfer of entire defense repertoires between bacterial strains

  • The 34-kilobase sequence containing retron EC67 represents such a defense island

2. Functional diversity among retron systems:

  • Different retron systems utilize diverse effector mechanisms:

    • Retron EC67: Effector fused to RT (unique arrangement)

    • Retron Ec48: Associated with transmembrane protein causing membrane permeability

    • Retron Ec78: Linked to PtuAB effector that degrades tRNATyr

    • Retron Ec73: Contains ribosyltransferase and DNA-binding domains

3. Complementary defense strategies:

  • Retrons provide defense through abortive infection (Abi), a "last resort" mechanism

  • This complements other defense strategies:

    • Restriction-modification systems: Direct cleavage of invading DNA

    • CRISPR-Cas systems: Adaptive immunity through targeted degradation

    • Surface modification systems: Prevention of phage adsorption

4. "Guard" hypothesis:

  • Some retrons appear to monitor the integrity of other defense components

  • Retron Ec48 specifically "guards" RecBCD, activating when phages inhibit this complex

  • Retron EC67 may similarly monitor other cellular components, as evidenced by its activation by phage proteins involved in DNA metabolism

Retron SystemEffector TypePhages ResistedTriggering Mechanism
EC67RT-fused effectorT2, T5, ΦSP15DenB (T2), Protein A1 (T5/ΦSP15)
Ec48Transmembrane proteinλ-vir, T7RecBCD inhibition (Gam, gp5.9)
Ec78PtuAB (tRNATyr degradation)T5, ΦSP15Exonuclease D15
Ec73RibosyltransferaseMultiple phage familiesNot fully characterized

5. Phage counter-defense priorities:

  • Phages have evolved specific counter-mechanisms against retrons:

    • Rad protein targets multiple retron systems by degrading ncRNA

    • tRNA supplementation counters tRNA-targeting retrons

  • The diversity of counter-strategies suggests retrons pose significant barriers to phage replication

6. Regulatory connections:

  • The presence of GATC sequences (Dam methylation sites) in the promoter region of retron EC67 RT gene suggests potential regulatory connections to DNA methylation systems

  • This may enable coordination between different defense systems through shared regulatory networks

How does the unique fusion of effector and reverse transcriptase genes in Retron EC67 impact function?

The fusion of the effector gene to the reverse transcriptase (RT) gene in retron EC67 represents a distinctive structural arrangement with significant functional implications:

1. Structural organization:

  • Unlike other retrons where RT and effector are separate proteins, retron EC67 encodes them as a single fusion protein

  • This creates a multidomain protein where the RT and effector functions are physically linked

  • The fusion may contain linker regions that enable proper folding and function of both domains

2. Functional advantages:

  • Co-translational production ensures stoichiometric 1:1 ratio of RT and effector domains

  • Physical linkage enables direct signal transduction between sensing (RT) and effector activities

  • The arrangement potentially provides faster response to phage invasion compared to systems requiring assembly of separate components

3. Evolutionary perspectives:

  • The fusion may represent a specialized adaptation to particular phage threats

  • It could have evolved to prevent phage-encoded inhibitors from disrupting the interaction between separate RT and effector proteins

  • Analysis of the A proteins of P2-EC67 shows they are slightly truncated, having two fewer amino acids than the standard P2 phage proteins , suggesting ongoing evolutionary adaptation

4. Comparative analysis with other retrons:

  • Most characterized retrons have separate genes for RT and effector proteins:

    • Retron Ec78 has separate genes encoding RT and the PtuAB effector

    • Retron Ec48 encodes a distinct transmembrane protein effector

  • The fusion in EC67 represents an alternative evolutionary solution to coordinating retron components

5. Mechanistic implications:

  • In systems with separate RT and effector (like Retron-Eco11), the presence of msDNA is essential for effector binding to the RT

  • The fusion in EC67 may eliminate this requirement or alter the regulatory dynamics

  • Conformational changes in the RT domain upon sensing phage components could directly activate the fused effector domain

6. Research challenges:

  • The fusion architecture presents unique challenges for experimental characterization

  • Domain separation experiments (creating separate RT and effector proteins) would help assess the importance of the fusion

  • Point mutations at domain interfaces could identify critical residues for interdomain communication

What methodologies are most effective for studying Retron EC67 activation during phage infection?

Investigating the activation dynamics of Retron EC67 during phage infection requires sophisticated methodological approaches:

1. Real-time monitoring systems:

  • Fluorescent reporter fusions to track retron component localization and interactions

  • FRET-based biosensors to detect conformational changes in the RT-effector fusion protein

  • Time-lapse microscopy to visualize cellular responses during infection

2. Phage escape mutant analysis:

  • Challenge bacteria containing Retron EC67 with phages and isolate "escaper" mutants

  • Genome sequencing of these mutants has identified mutations in specific proteins:

    • DenB in T2 phage escapers

    • Protein A1 in T5n/ΦSP15m escapers

  • These mutated proteins reveal the specific phage components that trigger retron activation

3. Biochemical interaction studies:

  • Co-immunoprecipitation to identify proteins interacting with Retron EC67 components

  • Mass spectrometry proteomics to characterize complex formation during infection

  • In vitro reconstitution of the activation pathway using purified components

4. Genetic dissection approaches:

  • Point mutations in key residues of RT and effector domains

  • Complementation studies with mutant variants

  • Domain swapping experiments with other retron systems

5. msDNA dynamics monitoring:

  • Northern blotting to detect changes in ncRNA levels during infection

  • Specialized extraction protocols for msDNA followed by quantification

  • Next-generation sequencing approaches to analyze msDNA populations

Experimental workflow for studying retron activation:

  • Engineer bacterial strains expressing Retron EC67 with epitope-tagged components

  • Infect with phage at defined multiplicity of infection (MOI)

  • Harvest samples at various timepoints post-infection

  • Perform cellular fractionation to isolate different compartments

  • Analyze protein complexes by immunoprecipitation and mass spectrometry

  • Extract and quantify msDNA production

  • Measure cell viability to correlate with defense activation

  • Analyze phage production to confirm abortive infection

Table: Key assays for monitoring Retron EC67 activation

AssayMeasurementTechnical considerations
RT-qPCRncRNA and msDNA levelsRequires specialized primers for branched molecules
Western blotProtein expressionUse antibodies against RT-effector fusion
Cell viabilityAbortive infectionCFU counting or live/dead staining
Phage titeringDefense effectivenessPlaque assays with and without retron
RNA hybridizationncRNA degradation by RadDesign probes specific to retron ncRNA
Fluorescence microscopyProtein localizationRequires functional fluorescent fusions

What bioinformatic approaches can identify potential functions of uncharacterized domains in Retron EC67?

Bioinformatic analysis offers powerful approaches to predict functions of uncharacterized domains in Retron EC67:

1. Comparative sequence analysis:

  • PSI-BLAST and HHpred searches to identify distant homologs

  • Multiple sequence alignments to identify conserved residues across retron systems

  • Phylogenetic analysis to trace evolutionary relationships with other retrons

  • Retron EC67 has been shown to be part of a distinct evolutionary lineage within retron systems

2. Structural prediction and analysis:

  • AlphaFold or RoseTTAFold to generate protein structure models

  • Structure comparison using tools like FATCAT to identify similar proteins

    • Similar analysis of related retrons revealed structural similarity between effector domains and xanthine-guanine-hypoxanthine PRTase (RMSD of 3.07 over 130 Cα atoms)

  • Binding site prediction to identify potential interaction surfaces

  • Molecular dynamics simulations to explore conformational dynamics

3. Domain architecture analysis:

  • InterProScan and CDD searches to identify recognized domains

  • Transmembrane helix prediction (TMHMM, Phobius)

  • Signal peptide prediction (SignalP)

  • DNA/RNA binding motif prediction

  • Some retron effectors contain DNA-binding domains like the winged helix-turn-helix domain found in related systems

4. Genomic context analysis:

  • Examination of genes surrounding retron EC67 in the 34kb genomic island

  • This has revealed interesting features like an open reading frame with 44% sequence identity to E. coli Dam methylase

  • Analysis of conserved gene neighborhoods across different bacterial strains

5. Structural RNA analysis for the ncRNA component:

  • RNA secondary structure prediction (RNAfold, Mfold)

  • Identification of conserved structural motifs across retron systems

  • Detection of potential regulatory RNA elements

6. Machine learning approaches:

  • Deep learning models to predict protein function from sequence

  • Network-based approaches integrating multiple data types

  • Prediction of protein-protein interaction networks

7. Evolutionary analysis:

  • Selection pressure analysis to identify functionally important residues

  • Horizontal gene transfer detection

  • Analysis of the 26-base-pair direct repeats flanking the 34kb element containing retron EC67

8. Database integration:

  • Cross-referencing with specialized databases:

    • Phage genome databases

    • Bacterial defense system databases (like DefenseFinder)

    • Prokaryotic protein family databases

Example bioinformatic workflow:

  • Extract protein sequences for the RT-effector fusion from retron EC67

  • Perform domain prediction and boundary identification

  • Generate multiple sequence alignments of homologous proteins

  • Identify conserved residues and potential catalytic sites

  • Predict 3D structures using AlphaFold2

  • Compare structures to known protein domains using structural alignment tools

  • Analyze potential binding interfaces and active sites

  • Generate testable hypotheses about domain functions

How does the msDNA produced by Retron EC67 differ from other retron-generated msDNAs?

The msDNA produced by Retron EC67 exhibits distinct characteristics compared to those generated by other retron systems:

1. Size and structure:

  • msDNA-EC67 is approximately 67 bases in length, as implied by its designation

  • This differs from other msDNAs, such as those from Retron Ec48 which are typically 70-80 nucleotides

  • Each retron system produces msDNA with unique secondary structure patterns

2. RNA-DNA junction:

3. Termination mechanisms:

  • Retron reverse transcriptases lack an RNase H domain and depend on endogenous RNase H1 to remove RNA templates

  • RNase H1 also plays a crucial role in determining the termination point of RT-DNA, with differing effects across retron subtypes

  • The specific termination pattern for EC67 msDNA may be unique to this system

4. Sequence conservation:

  • Comparative analysis of msDNA sequences reveals system-specific conservation patterns

  • These patterns likely reflect functional constraints related to target recognition or structural requirements

  • The sequence of msDNA-EC67 would be expected to show conservation specific to its functional role

5. Role in complex formation:

  • In some retron systems like Retron-Eco11, the msDNA is essential for effector protein binding to the RT

  • When mutations prevent msDNA formation, effector proteins fail to associate with the retron complex

  • The importance of msDNA for complex formation may vary between different retron systems

6. Functional implications:

  • The unique characteristics of each msDNA likely reflect adaptation to specific functional roles

  • These may include recognition of particular cellular targets or phage components

  • The exact mechanism by which msDNA-EC67 contributes to defense function remains to be fully characterized

7. Evolutionary context:

  • The 34kb genomic island containing retron-EC67 suggests it was acquired through horizontal gene transfer

  • This may have influenced the evolution of its msDNA structure compared to retrons with different evolutionary histories

What techniques are most effective for developing and validating antibodies against Retron EC67 proteins?

Developing high-quality antibodies against Retron EC67 proteins requires systematic approaches spanning antigen design through validation:

1. Antigen design and preparation:

  • Sequence analysis for immunogenic regions:

    • Analyze the RT-effector fusion protein for hydrophilic, surface-exposed regions

    • Identify unique sequences that differentiate EC67 from other retrons

    • Avoid transmembrane regions which may be poorly immunogenic

  • Multiple antigen strategies:

    • Recombinant full-length protein with affinity tags

    • Specific domains expressed separately (RT domain, effector domain)

    • Synthetic peptides (15-20 amino acids) from predicted epitope regions

    • Consider both N-terminal and C-terminal regions for comprehensive coverage

2. Expression and purification systems:

  • Bacterial expression:

    • E. coli BL21(DE3) with T7-based vectors for high yield

    • Codon optimization for improved expression

    • Fusion tags (His, GST, MBP) to improve solubility and facilitate purification

  • Purification workflow:

    • Affinity chromatography (IMAC for His-tagged proteins)

    • Ion exchange chromatography to remove contaminants

    • Size exclusion chromatography for final polishing

    • Quality control by SDS-PAGE and mass spectrometry

3. Immunization strategies:

  • Polyclonal antibodies:

    • Immunize rabbits with purified antigen using a prime-boost schedule

    • Collect serum and purify IgG using protein A/G affinity chromatography

  • Monoclonal antibodies:

    • Immunize mice followed by hybridoma generation

    • Screen hybridoma supernatants against recombinant protein

    • Subclone positive hybridomas to ensure monoclonality

  • Recombinant antibodies:

    • Phage display libraries from immunized animals

    • Selection against immobilized target protein

    • Affinity maturation through directed evolution

4. Comprehensive validation workflow:

Validation TechniquePurposeControls Required
Western blotConfirm specific binding to target proteinLysates with/without retron EC67 expression
ImmunoprecipitationVerify ability to pull down native proteinPre-immune serum, non-target proteins
ImmunofluorescenceDetermine localization in bacterial cellsSecondary antibody only, competing peptide
Dot blot titrationDetermine sensitivity and optimal dilutionSerial dilutions of purified antigen
Cross-reactivity testingAssess specificityRelated retron proteins, bacterial lysates
Peptide competitionConfirm epitope specificitySpecific and non-specific peptides

5. Epitope mapping:

  • Peptide arrays to identify specific binding regions

  • Mutagenesis of key residues to fine-map the epitope

  • Hydrogen-deuterium exchange mass spectrometry to identify surface-exposed regions

6. Application-specific validation:

  • For research involving phage infection, validate antibody performance in infection conditions

  • Test recognition of the protein in different conformational states

  • Assess compatibility with fixation methods for microscopy applications

7. Documentation and quality control:

  • Establish standard operating procedures for antibody production and testing

  • Document all validation results with appropriate positive and negative controls

  • Store validation data including original images of western blots and immunofluorescence

High-quality, validated antibodies against Retron EC67 proteins would enable detailed studies of protein localization, complex formation, and conformational changes during phage infection, significantly advancing our understanding of this bacterial defense system.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.